Publication | Closed Access
Intanza® 15mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses
30
Citations
16
References
2012
Year
VaccinationCross-protectionVaccine DevelopmentImmunologyVirologyIntradermal Influenza VaccineIntanza® 15McgInfluenza VaccineCross-reactive Antibody ResponsesVaccine DesignFlu VaccinationMedicineViral ImmunityInfluenza Vaccines
| Year | Citations | |
|---|---|---|
Page 1
Page 1